The ED50and ED95of Intrathecal Isobaric Bupivacaine with Opioids for Cesarean Delivery
- 1 September 2005
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 103 (3) , 606-612
Abstract
Background: The ideal intrathecal isobaric bupivacaine dose for cesarean delivery anesthesia is uncertain. While small doses (5-9 mg) of bupivacaine may reduce side effects such as hypotension, they potentially increase spinal anesthetic failures. This study determined the ED50 and ED95 of intrathecal isobaric bupivacaine (with adjuvant opioids) for cesarean delivery. Methods: After institutional review board approval and written informed consent were obtained, 48 parturients undergoing elective cesarean delivery under combined spinal-epidural anesthesia were enrolled in this double-blind, randomized, dose-ranging study. Patients received a 5-, 6-, 7-, 8-, 9-, 10-, 11-, or 12-mg intrathecal isobaric bupivacaine dose with 10 microg fentanyl and 200 microg morphine. Overall anesthetic success was recorded when no intraoperative epidural supplement was required during the cesarean delivery. ED50 and ED95 values for overall anesthetic success were determined using a logistic regression model. Results: ED50 and ED95 values for overall anesthetic success were 7.25 and 13.0 mg, respectively. No advantages for low doses could be demonstrated with regard to hypotension, nausea, vomiting, pruritus, or maternal satisfaction, although this study was underpowered to detect significant differences in secondary outcome variables. Conclusions: The ED50 and ED95 values (7.25 and 13.0 mg, respectively) for intrathecal isobaric bupivacaine in this circumstance are similar to values the authors determined recently for hyperbaric bupivacaine using similar methodology. These ED50 and ED95 values are significantly higher than those advocated in previous reports in which success was claimed using lower intrathecal bupivacaine doses. The current study used stricter criteria to define "successful" anesthesia and support the use of larger bupivacaine doses to ensure adequate patient comfort.Keywords
This publication has 18 references indexed in Scilit:
- ED50and ED95of Intrathecal Hyperbaric Bupivacaine Coadministered with Opioids for Cesarean DeliveryAnesthesiology, 2004
- Spinal Ropivacaine for Cesarean Delivery: A Comparison of Hyperbaric and Plain SolutionsAnesthesia & Analgesia, 2002
- Spinal anaesthesia for Caesarean section with bupivacaine 5 mg ml–1 in glucose 8 or 80 mg ml–1British Journal of Anaesthesia, 2001
- Low-Dose Bupivacaine-Fentanyl Spinal Anesthesia for Cesarean DeliveryRegional Anesthesia & Pain Medicine, 2000
- The influence of baricity on the haemodynamic effects of intrathecal bupivacaine 0.5%Anaesthesia, 1999
- Small-Dose Hyperbaric Versus Plain Bupivacaine During Spinal Anesthesia for Cesarean SectionAnesthesia & Analgesia, 1998
- Densities of Dextrose-Free Intrathecal Local Anesthetics, Opioids, and Combinations Measured at 37 degrees CAnesthesia & Analgesia, 1997
- Incidence of Visceral Pain during Cesarean SectionAnesthesia & Analgesia, 1989
- SUBARACHNOID ANALGESIA FOR CAESAREAN SECTIONBritish Journal of Anaesthesia, 1987
- Plain or Hyperbaric Bupivacaine for Spinal AnesthesiaAnesthesia & Analgesia, 1986